Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis

被引:187
作者
Celikbilek, Mehmet [1 ]
Dogan, Serkan [1 ]
Ozbakir, Omer [1 ]
Zararsiz, Gokmen [2 ]
Kucuk, Hamit [3 ]
Gursoy, Sebnem [1 ]
Yurci, Alper [1 ]
Guven, Kadri [1 ]
Yucesoy, Mehmet [1 ]
机构
[1] Erciyes Univ, Sch Med, Dept Gastroenterol & Hepatol, Kayseri, Turkey
[2] Erciyes Univ, Sch Med, Dept Biostat & Med Informat, Kayseri, Turkey
[3] Erciyes Univ, Sch Med, Dept Internal Med, Kayseri, Turkey
关键词
Neutrophil-to-lymphocyte ratio; ulcerative colitis; noninvasive monitoring; THERAPY; MANAGEMENT; MARKERS; CANCER; COHORT;
D O I
10.1002/jcla.21564
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundBlood neutrophil-to-lymphocyte (N/L) ratio is an indicator of the overall inflammatory status of the body, and an alteration in N/L ratio may be found in ulcerative colitis (UC) patients. The aims of this study were to investigate the utility of N/L ratio as a simple and readily available predictor for clinical disease activity in UC. J. Clin. Lab. Anal. 27:72-76, 2013. (c) 2012 Wiley Periodicals, Inc. MethodsTwenty-six patients and 28 healthy controls were enrolled in the study. The neutrophil and lymphocyte counts were recorded, and the N/L ratio was calculated from these parameters. The extent of disease classified according to the Montreal classification, clinical disease activity was evaluated using a modified Truelove-Witts severity index, and endoscopic disease activities were classified according to Schroder et al. ResultsThe serum N/L ratios of active patients were significantly higher than those of inactive UC and controls (P < 0.001). The optimum N/L ratio cut-off point for active UC was 2.47. There was no significant difference between inflammation parameters, disease extension, and disease activity. ConclusionOur results demonstrate that N/L ratio is higher in patients with active UC compared with controls and UC patients in remission and a cut-off value of 2.47 can be used to identify patients with active ulcerative colitis.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 23 条
[1]   Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease [J].
Alkhouri, Naim ;
Morris-Stiff, Gareth ;
Campbell, Carla ;
Lopez, Rocio ;
Tamimi, Tarek Abu-Rajab ;
Yerian, Lisa ;
Zein, Nizar N. ;
Feldstein, Ariel E. .
LIVER INTERNATIONAL, 2012, 32 (02) :297-302
[2]   Neutrophil count and infarct size in patients with acute myocardial infarction [J].
Avanzas, P ;
Quiles, J ;
de Sá, EL ;
Sánchez, A ;
Rubio, R ;
García, E ;
López-Sendón, JL .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 (01) :155-156
[3]   Neutrophil-Lymphocyte Ratio as a Predictor of Adverse Outcomes of Acute Pancreatitis [J].
Azab, Basem ;
Jaglall, Neil ;
Atallah, Jean Paul ;
Lamet, Ari ;
Raja-Surya, Venkat ;
Farah, Bachir ;
Lesser, Martin ;
Widmann, Warren D. .
PANCREATOLOGY, 2011, 11 (04) :445-452
[4]   Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis [J].
Bitton, A ;
Peppercorn, MA ;
Antonioli, DA ;
Niles, JL ;
Shah, S ;
Bousvaros, A ;
Ransil, B ;
Wild, G ;
Cohen, A ;
Edwardes, MDD ;
Stevens, AC .
GASTROENTEROLOGY, 2001, 120 (01) :13-20
[5]   Current and future diagnostic approaches: From serologies to imaging [J].
Bruining D.H. ;
Loftus Jr. E.V. .
Current Gastroenterology Reports, 2007, 9 (6) :489-496
[6]   Current management of severe ulcerative colitis [J].
Caprilli, Renzo ;
Viscido, Angelo ;
Latella, Giovanni .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (02) :92-101
[7]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786
[8]   Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention [J].
Duffy, BK ;
Gurm, HS ;
Rajagopal, V ;
Gupta, R ;
Ellis, SG ;
Bhatt, DL .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :993-996
[9]   Intestinal epithelial pathobiology: past, present and future [J].
Gewirtz, AT ;
Liu, YA ;
Sitaraman, SV ;
Madara, JL .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (06) :851-867
[10]   Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting [J].
Gibson, Patrick H. ;
Croal, Bernard L. ;
Cuthbertson, Brian H. ;
Small, Gary R. ;
Ifezulike, Adaeze I. ;
Gibson, George ;
Jeffrey, Robert R. ;
Buchan, Keith G. ;
El-Shafei, Hussein ;
Hillis, Graham S. .
AMERICAN HEART JOURNAL, 2007, 154 (05) :995-1002